EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Protein Lactylation in Cancer: From Mechanisms to Therapy

Wentian Huang, Ping Hu, Shun Wang, Xide Zhang, Ziran Ye, Shengqiang Chen, Fu Gao, Yuanyuan Chen iD, Yanyong Yang

MedComm · 2026-11 · 7 (11)

DOI: 10.1002/mco2.71106 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 31.10.2026. Verfasst von Wentian Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Medicine Faculty of Naval Medicine Naval Medical University Shanghai China. Die Arbeit nennt 393 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein lactylation has emerged as a metabolically responsive posttranslational modification linking lactate accumulation to epigenetic and functional adaptation in cancer. Initially identified on histones, lactylation is now recognized on diverse nonhistone proteins involved in DNA damage repair, immune regulation, redox homeostasis, metabolic remodeling, and cellular plasticity. However, current evidence remains fragmented across treatment modalities, and many reported lactylation events lack site‐specific functional validation and translational assessment. This review addresses this gap by integrating the metabolic and enzymatic basis of protein lactylation with its roles in chemotherapy, radiotherapy, targeted therapy, and immunotherapy. We critically examine how lactylation may promote tumor persistence under therapeutic pressure by enhancing genome maintenance, immune evasion, stress‐survival signaling, metabolic adaptability, and tumor microenvironment remodeling. We also evaluate emerging strategies targeting lactate production and transport, lactylation‐regulating enzymes, and functionally validated substrates, including their potential use in combination therapies. Finally, we discuss major barriers to clinical translation, including incomplete characterization of regulatory enzymes, limitations in site‐specific lactylome mapping, insufficient causal validation, lack of clinically qualified biomarkers, tumor metabolic heterogeneity, and challenges in achieving therapeutic selectivity. Collectively, protein lactylation represents an emerging mechanistic framework for understanding cancer treatment adaptation and a potentially targetable axis whose clinical relevance requires rigorous validation.

Schlagwörter

Stichwörter der Autor:innen

DNA damage responselactate metabolismprotein lactylationtherapeutic resistancetumor microenvironment

Autor:innen und Institutionen

  • Department of Radiation Medicine Faculty of Naval Medicine Naval Medical University Shanghai China.
  • School of Public Health China Medical University Shenyang China.
  • Department of Hepatic Surgery VI Eastern Hepatobiliary Surgery Hospital Naval Medical University Shanghai China.
  • Shanghai Key Laboratory of Nautical Medicine and Translation of Drugs and Medical Devices Shanghai China.

ORCID-Profile: Yuanyuan Chen

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Huang, W., Hu, P., Wang, S., Zhang, X., Ye, Z., Chen, S., Gao, F., Chen, Y., & Yang, Y. (2026). Protein Lactylation in Cancer: From Mechanisms to Therapy. MedComm, 7(11). https://doi.org/10.1002/mco2.71106

Vancouver

Huang W, Hu P, Wang S, Zhang X, Ye Z, Chen S, et al. Protein Lactylation in Cancer: From Mechanisms to Therapy. MedComm. 2026;7(11). doi:10.1002/mco2.71106

BibTeX
@article{Huang2026,
  author = {Huang, Wentian and Hu, Ping and Wang, Shun and Zhang, Xide and Ye, Ziran and Chen, Shengqiang and Gao, Fu and Chen, Yuanyuan and Yang, Yanyong},
  title = {Protein Lactylation in Cancer: From Mechanisms to Therapy},
  journal = {MedComm},
  year = {2026},
  volume = {7},
  number = {11},
  doi = {10.1002/mco2.71106}
}
Kostenlos starten →